Related Experiment Video
Updated: Mar 21, 2026
09:30
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
4.6K
Current Practices in Global/International Advanced Pharmacy Practice Experiences: Home/Host Country or
Naser Z Alsharif1, Adnan Dakkuri2, Jeanine P Abrons3
1Creighton University Medical Center School of Pharmacy and Health Professions, Omaha, Nebraska.
American Journal of Pharmaceutical Education
|May 13, 2016
Summary
This paper offers guidelines for establishing successful international advanced pharmacy practice experiences (G/I APPEs). It provides recommendations for both home and host countries to ensure quality global pharmacy education.
Area of Science:
- Pharmacy Education
- Global Health Initiatives
- International Academic Partnerships
Background:
- Increasing international outreach by pharmacy schools necessitates standardized guidelines.
- Existing frameworks for global/international advanced pharmacy practice experiences (G/I APPEs) require comprehensive updates.
- The need for structured guidance in establishing and maintaining international pharmacy education programs is evident.
Purpose of the Study:
- To provide current practice guidelines for establishing and maintaining successful global/international advanced pharmacy practice experiences (G/I APPEs).
- To offer specific recommendations for both home and host countries, as well as host sites and institutions.
- To serve as a resource for developing new G/I APPEs and improving existing partnerships in international pharmacy education.
Main Methods:
- A comprehensive literature review of databases and internet searches from 2000-2014 using specific keywords.
- Examination of educational documents, including syllabi and memoranda of understanding (MoUs) from pharmacy programs.
- A preliminary draft followed by a roundtable discussion at the 2014 American Association of Colleges of Pharmacy Annual Meeting for review and refinement.
Main Results:
- Recommendations for host countries cover travel logistics (passports, visas, flights), safety, accommodation, transport, travel advisories, health, and finances.
- Recommendations for home countries address the vetting process for G/I APPE sites, MoU development, and site expectations.
- Guidelines are provided for continuous quality improvement of international pharmacy education partnerships.
Conclusions:
- The developed guidelines offer a practical framework for institutions seeking to establish or enhance international advanced pharmacy practice experiences.
- Adherence to these recommendations can foster more robust and effective global collaborations in pharmacy education.
- This resource supports the growth and quality assurance of international pharmacy practice experiences worldwide.
More Related Videos
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
74
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
74
01:28International Nursing Organizations II
1.4K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.4K
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
222
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
222
01:28Dosage Regimens: Designs and Approaches
449
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
449
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
236
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
236
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
70
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
70